The 4894.T stock plunged 16.58% to JPY 6740.00 at the JPX close on 03 Mar 2026, marking a heavy intraday move on higher volume. Trading hit 487,400.00 shares versus a 50-day average of 283,396.00, sending the biotech name sharply lower. Shares opened at JPY 7450.00 and traded as high as JPY 7460.00 before collapsing to the day low. Investors cite weaker near-term outlook and profit-taking after recent gains.

4894.T stock: intraday price action and volume

Shares of Cuorips Inc. (4894.T) closed at JPY 6740.00, down 16.58% on the day. Volume was 487,400.00, about 2.24 times average volume. The stock opened at JPY 7450.00 and hit a day high of JPY 7460.00. The move erased recent gains and pushed the price below the 50-day average of JPY 7647.80.

4894.T stock drivers: news, sector and sentiment

Market participants flagged a Reuters company update and profit-taking as catalysts. Reuters report on Cuorips key metrics published recent per-share data that traders checked during the session. The stock trades in the Healthcare sector on JPX. Healthcare peers held firmer, so the fall looks stock-specific and sentiment-driven.

Financials and valuation for 4894.T stock

Cuorips reports EPS -81.61 and a trailing PE -90.06, reflecting losses. Price-to-book is 12.09, and price-to-sales is 170.36. Cash per share is JPY 460.62 and book value per share is JPY 610.43. Market cap stands at JPY 60596413500.00. High PB and negative EPS highlight valuation risk versus Healthcare averages.

Technical picture and trading levels for 4894.T stock

Technicals show bearish momentum but possible oversold signals. RSI is 42.86 and ADX is 38.57, indicating a strong trend. The 50-day average is JPY 7647.80 and the 200-day average is JPY 6765.10. Immediate support is the session low JPY 6740.00 and resistance is JPY 7460.00. Traders note ATR JPY 849.30 implying larger daily swings.

Meyka Grade & Forecast for 4894.T stock

Meyka AI rates 4894.T with a score out of 100. Meyka AI rates 4894.T with a score out of 100: 69.08/100 (Grade B, HOLD). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a 12-month target of JPY 9613.48, compared with the current JPY 6740.00, implying an upside of 42.61%. Forecasts are model-based projections and not guarantees. For further data see our Cuorips page: Meyka: 4894.T stock page.

Outlook, price targets and risk for 4894.T stock

Near-term risk includes continued profit-taking and clinical or regulatory updates that could widen volatility. A conservative short-term technical target is JPY 6000.00 if selling persists. A 12-month base case target aligns with Meyka’s forecast near JPY 9500.00 and a bull case near JPY 12,000.00. Liquidity is moderate; shares outstanding total 8,244,410.00 and average volume is 283,396.00.

Final Thoughts

Cuorips (4894.T) ended the JPX session on 03 Mar 2026 down 16.58% at JPY 6740.00 on higher-than-normal volume. Fundamentals show negative EPS (-81.61) and high valuation ratios, while the balance sheet reflects strong cash per share (JPY 460.62) and a very high current ratio. Meyka AI’s model projects a 12-month target of JPY 9613.48, implying a 42.61% upside versus today’s close, but that view carries model risk. Traders should weigh the B (HOLD) Meyka grade and the stock-specific catalysts against sector performance. Short-term traders may focus on support at JPY 6740.00 and resistance near JPY 7647.80. Long-term investors must monitor clinical milestones and capital needs. Forecasts are model-based projections and not guarantees.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.